Denileukin Diftitox and Insulin degludec and liraglutide Subcutaneous
Determining the interaction of Denileukin Diftitox and Insulin degludec and liraglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: denileukin diftitox
Brand name: Ontak
Synonyms: n.a.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Denileukin Diftitox-Insulin degludec Subcutaneous
- Denileukin Diftitox-Insulin detemir
- Denileukin Diftitox-Insulin Detemir (Cartridges and Prefilled Syringes)
- Denileukin Diftitox-Insulin Detemir (Vials)
- Denileukin Diftitox-Insulin detemir Subcutaneous
- Denileukin Diftitox-Insulin glargine
- Insulin degludec and liraglutide Subcutaneous-Denorex Extra Strength
- Insulin degludec and liraglutide Subcutaneous-Denorex Topical
- Insulin degludec and liraglutide Subcutaneous-Denosumab
- Insulin degludec and liraglutide Subcutaneous-Denosumab Injection (Prolia)
- Insulin degludec and liraglutide Subcutaneous-Denosumab Injection (Xgeva)
- Insulin degludec and liraglutide Subcutaneous-Denosumab Subcutaneous